James Dow

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

Apostolia M. Tsimberidou, Philip Beer, Carrie Cartwright et al. · Clinical Cancer Research · 2021 · 67 citations · Full text

Medicine, Oncology, Pharmacology +13

Isocratic high-performance liquid chromatographic method for the separation of testosterone metabolites

Patricia Sanwald Ducray, Evelyn A. Blankson, Bertrand Duléry et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1995 · 47 citations

Life Sciences, Biochemistry, Endocrinology +14

Stereoselectivity of the carbonyl reduction of dolasetron in rats, dogs, and humans

James Dow, C. Berg · Chirality · 1995 · 28 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Use of electrospray ionization liquid chromatography-mass spectrometry to study the role of CYP2D^ in the in vitro metabolism of 5-hydroxytryptamine receptor antagonists

Patricia Sanwald Ducray, Murielle David, James Dow · Journal of Chromatography B Biomedical Sciences and Applications · 1996 · 19 citations

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug‐Drug Interaction Studies in Healthy Subjects

Mendel Jansen, Jeanne Mendell, Alexander Currie et al. · Clinical Pharmacology in Drug Development · 2018 · 13 citations

Medicine, Pharmacokinetics, Pharmacology +14